Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from MTA I: Other Tumors Posters

  • You have access
    The purpose of this study is to evaluate the clinical value of C-11 acetate (ACE) positron emission tomography (PET) in patients with brain gliomas.
    Soyoung Kim, Jongtae Cha, SANG HYUN HWANG, Narae Lee, Arthur Cho, Won Jun Kang and Mijin Yun
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1513;
  • You have access
    Clinical significance of quantitative analysis of 123I-MIBG SPECT/CT for pheochromocytoma and paraganglioma
    Ryusuke Nakamoto, Yuji Nakamoto, Takayoshi Ishimori and Kaori Togashi
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1509;
  • You have access
    PERFORMANCE OF 18F-FDG PET/CT FOR THE DIAGNOSIS OF OCCULT MALIGNANCY IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM
    Philippe ROBIN, Pierre Yves Le Roux, Benjamin Planquette, Sandrine Accassat, Pierre Marie Roy, Francis Couturaud, Nadia Ghazzar, Nathalie Prévot-Bitot, Olivier Couturier, Aurélien Delluc, Olivier Sanchez, Bernard Tardy, Grégoire Le Gal and Pierre Salaun
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1524;
  • You have access
    131I SPECT-CT imaging in management of differentiated thyroid carcinoma (DTC)
    Sonya Sergieva and Bozhil Robev
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1517;
  • You have access
    The diagnostic accuracy and value of 18F-FDOPA PET/CT in assessment of neuroendocrine tumours of gastroenteropancreatic and thoracic origin
    Kenny Sek, Don Wilson and Francois Benard
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1504;
  • You have access
    Heterogeneity in Somatostatin-Receptor(SSTR-)PET/CT can Predict Response to Radiopeptide Therapy and Overall Survival in Patients with SSTR-expressing Tumors - a Multicenter Retrospective Trial
    Rudolf Werner, Constantin Lapa, Harun Ilhan, Lazslo Papp, Frank Bengel, Markus Essler, Imke Schatka, Sebastian Lehner, Peter Bartenstein and Ralph Bundschuh
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1503;
  • You have access
    Focal bone activity on F18-FDG PET/CT images in oncology patients - How relevant is it clinically ?
    Gunjan Garg, DaSilva Raphaella, Mimi Kim, Love Charito, Tony Abraham and David Milstein
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1519;
  • You have access
    18F-fluciclovine (FACBC) PET/CT in residual or recurrent gliomas
    Trond Bogsrud, Ayca Loendalen, Petter Brandal, Cathrine Saxhaug and Tore Bach-Gansmo
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1512;
  • You have access
    Diagnostic and prognostic values of 18F-FDG PET/CT in cervical nodal metastatic carcinoma of unknown primary site
    Xiaoli Lan, Honghong Liu and Yongxue Zhang
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1523;
  • You have access
    Short PET/MR protocols perform as well as PET/CT for solid tumor staging
    Michael Soussan, Claude Comtat, Vicent Brulon, Irene Buvat and Ourkia Badia Helal
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1528;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 10
SNMMI

© 2025 SNMMI

Powered by HighWire